(Q37557598)

21 August 2017

1 reference

title

Alpha-2 adrenergic agonists in children with inattention, hyperactivity and impulsiveness (English)

1 reference

21 August 2017

1

1 reference

PubMed ID

19621977

21 August 2017

language of work or name

1 reference

1 January 2009

1 reference

21 August 2017

1 reference

21 August 2017

23 Suppl 1

1 reference

21 August 2017

43-49

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200923000-00006

21 August 2017

0 references

cites work

The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00023210-200923000-00006

Treatment of ADHD in children with tics: a randomized controlled trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00023210-200923000-00006

Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis

21 January 2018

1 reference

12 December 2020

Clonidine in Tourette's syndrome

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Hallucinations associated with initiation of guanfacine

1 reference

12 December 2020

The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes.

1 reference

12 December 2020

Anxiolytics, adrenergic agents, and naltrexone

1 reference

12 December 2020

Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Guanfacine as an alpha-2-agonist inducer of growth hormone secretion--a comparison with clonidine

1 reference

12 December 2020

Guanfacine, but not clonidine, improves planning and working memory performance in humans

1 reference

12 December 2020

Hyperadrenergic state following acute withdrawal from clonidine used at supratherapeutic doses.

1 reference

12 December 2020

An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder

1 reference

12 December 2020

Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial

1 reference

12 December 2020

A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

1 reference

12 December 2020

Centrally acting antihypertensive agents: an update

1 reference

12 December 2020

Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial.

1 reference

12 December 2020

Gene targeting--homing in on alpha 2-adrenoceptor-subtype function

1 reference

12 December 2020

Guanfacine in children with autism and/or intellectual disabilities

1 reference

12 December 2020

Right inferior prefrontal cortex mediates response inhibition while mesial prefrontal cortex is responsible for error detection.

1 reference

12 December 2020

Peer tutoring for children with attention deficit hyperactivity disorder: effects on classroom behavior and academic performance

1 reference

12 December 2020

Guanfacine and secondary mania in children

1 reference

12 December 2020

The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

1 reference

12 December 2020

Does guanfacine cause hallucinations in children?

1 reference

12 December 2020

A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder

1 reference

12 December 2020

Neuropsychiatric effects of guanfacine in children with mild tourette syndrome: a pilot study

1 reference

12 December 2020

Contemporary assessment and pharmacotherapy of Tourette syndrome

1 reference

12 December 2020

Clonidine blocks acute opiate-withdrawal symptoms

1 reference

12 December 2020

Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience

1 reference

12 December 2020

Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex.

1 reference

12 December 2020

Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes

1 reference

12 December 2020

Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction

1 reference

12 December 2020

A prospective open trial of guanfacine in children with pervasive developmental disorders.

1 reference

12 December 2020

10.2165/00023210-200923000-00006

Identifiers

DOI

1 reference

PubMed ID

19621977

Dimensions Publication ID

21 August 2017

0 references

1 reference

PubMed ID

19621977